Patient Care URMC’s First Chief of Child Neurology Dies By URochester Medicine Communications May. 24, 2010 Frederick A. Horner, M.D., the first chief of Child Neurology at the University of Rochester School of Medicine and Dentistry, died April 20, 2010, at the age of 90.
Patient Care Variations in Decisions for Care of Patients with Brain Injury “Disturbing” By Mark Michaud May. 12, 2010 Treatment decisions involving patients with severe brain injury vary widely between medical institutions, and appear to be more driven by hospital and physician practices and priorities. In an ...
Research URMC Named Batten Disease Center of Excellence By URochester Medicine Communications May. 11, 2010 The Batten Disease Support and Research Association named the University of Rochester Medical Center (URMC) a Batten Disease Center of Excellence today because of its comprehensive services for ...
Research Heart Drug Effective for Treating Symptom of Muscular Dystrophy By URochester Medicine Communications May. 3, 2010 A medication most often used to treat heart arrhythmias also reduces a central symptom of myotonic dystrophy, the most common type of muscular dystrophy in adults. The findings about the medication ...
Research URMC Receives $4.5 Million in NYS Stem Cell Grants By Mark Michaud Mar. 25, 2010 The University of Rochester Medical Center has received a total of $4.5 million in funding from the Empire State Stem Cell Board for research in neurological disease, cancer, cardiovascular disease, ...
Research New Center to Focus on Early Stage Clinical Research By Mark Michaud Mar. 2, 2010 A new initiative at the University of Rochester Medical Center will provide academic and industry researchers the expertise and scientific collaboration necessary to conduct early stage clinical ...
Research Drug Shows Promise for Huntington’s Disease By Mark Michaud Feb. 8, 2010 An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington’s disease appears to be safe and may improve cognition. That is the conclusion of a study ...
Research New Multiple Sclerosis Drug has URMC Ties By Mark Michaud Jan. 22, 2010 The Food and Drug Administration has approved the drug fampridine-SR for the treatment of multiple sclerosis. Researchers at the University of Rochester Medical Center have been evaluating the ...
Research Impact of FDA Safety Warnings Examined By Mark Michaud Jan. 11, 2010 A study published today in the Archives of Internal Medicine examines the impact of a safety warning issued by the Food and Drug Administration for commonly prescribed antipsychotic medications. The ...
Research Rochester Neurologist Takes a Lead Role Tackling Charcot-Marie-Tooth By URochester Medicine Communications Dec. 30, 2009 Neurologist David Herrmann, MBBCh, associate professor of Neurology and of Pathology and Laboratory Medicine at the University of Rochester Medical Center, is taking part in a newly funded nationwide ...
